Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
HRMY

Harmony Biosciences Holdings (HRMY) stock: insider trades, news & valuation

Heavy selling
Close · Oct 9, 2026 $40.28 +1.7% on the day +50.4% over 12 months 52-week range $25.90 – $42.86

Share price and insider trades

HRMY closeInsider buyInsider sale
2530354045NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $34,400 on 2026-09-17 · Kumar BudurSold $77,418 on 2026-09-16 · Kumar BudurSold $119,945 on 2025-11-21 · Sandip KapadiaSold $139,164 on 2026-01-26 · Sandip KapadiaSold $230,890 on 2026-09-04 · Kumar BudurSold $752,919 on 2026-01-15 · Sandip KapadiaSold $790,800 on 2025-12-05 · Sandip KapadiaSold $1,040,173 on 2025-12-12 · Jeffrey M. DaynoSold $1,222,232 on 2026-09-08 · Kumar BudurSold $1,543,429 on 2026-09-18 · Kumar Budur
Bought, 12 months$0
Sold, 12 months$6.0M
Insiders buying0
Insiders selling3

Harmony Biosciences Holdings insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 3 sold $6.0M of HRMY stock on the open market.

HRMY insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $2.0M sold (4 trades)Q4 2025Q1 2026: $892K sold (2 trades)Q1 2026Q2 2026Q3 2026: $3.1M sold (7 trades)Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0$3.1M7
Q2 2026—0—0
Q1 2026—0$892K2
Q4 2025—0$2.0M4

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day0.7×Last 5 sessions
Insiders' paper profit—On all tracked purchases —

Summary

Over the past 12 months, 0 Harmony Biosciences Holdings, Inc. insiders reported open-market purchases totaling $0, while 3 insiders reported sales totaling $6.0M. 13 of 13 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Sep 18SEC Kumar BudurChief Medical Officer Sell Plan 35,85213,115 held (−73%) $43.05 $1.5M -6.4% —
Sep 18SEC Kumar BudurChief Medical Officer Sell Plan 1,80013,115 held (−12%) $43.01 $77K -6.3% —
Sep 18SEC Kumar BudurChief Medical Officer Sell Plan 80013,115 held (−6%) $43.00 $34K -6.3% —
Sep 9SEC Kumar BudurChief Medical Officer Sell Plan 22,95413,115 held (−64%) $43.10 $989K -6.5% —
Sep 9SEC Kumar BudurChief Medical Officer Sell Plan 5,50018,615 held (−23%) $41.98 $231K -4.0% —
Sep 9SEC Kumar BudurChief Medical Officer Sell Plan 4,50014,115 held (−24%) $42.25 $190K -4.7% —
Sep 9SEC Kumar BudurChief Medical Officer Sell Plan 1,00013,115 held (−7%) $42.79 $43K -5.9% —
Jan 28SEC Sandip KapadiaCFO Sell Plan 3,74624,521 held (−13%) $37.15 $139K +8.4% —
Jan 20SEC Sandip KapadiaCFO Sell Plan 20,961 $35.92 $753K +12.1% —
Dec 17SEC Jeffrey M. DaynoCEO, President Sell Plan 20,000 $40.11 $802K +0.4% —
Dec 17SEC Jeffrey M. DaynoCEO, President Sell Plan 5,933 $40.11 $238K +0.4% —
Dec 9SEC Sandip KapadiaCFO Sell Plan 20,000 $39.54 $791K +1.9% —
Nov 25SEC Sandip KapadiaCFO Sell Plan 3,427 $35.00 $120K +15.1% —

Insiders at Harmony Biosciences Holdings, Inc.

InsiderBoughtSoldLast filingScore
Kumar BudurChief Medical Officer — $3.1M Sep 18, 2026 —
Sandip KapadiaCFO — $1.8M Jan 28, 2026 —
Jeffrey M. DaynoCEO, President — $1.0M Dec 17, 2025 —

HRMY stock: common questions

Are Harmony Biosciences Holdings, Inc. insiders buying HRMY stock?

In the past 12 months, 0 insiders reported open-market purchases of HRMY worth $0.

Are Harmony Biosciences Holdings, Inc. insiders selling HRMY stock?

3 insiders reported sales worth $6.0M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is HRMY's 52-week range?

Over the past year HRMY has traded between $25.90 and $42.86. It last closed at $40.28 on Oct 9, 2026.